Similar Papers

Paper Title
Journal
Date
Author
Erythropoiesis-stimulating agents in cancer patients: ESMO Recommendations for use
D Scrijvers ... F Roila
Annals of Oncology | VOL. 20
D Scrijvers, et. al.D Scrijvers ... F Roila
01 May 2009
Key insights into present and future treatments of anaemia in CKD patients
A L M De Francisco
NDT Plus | VOL. 2
A L M De FranciscoA L M De Francisco
01 Jan 2009
Erythropoiesis Stimulating Agent (ESA) Use for Anemic Cancer and Chronic Kidney Disease (CKD) Patients in 2008: Advocacy for Conservative Use
Charles L Bennett ... Stephen Y Lai
Blood | VOL. 112
Charles L Bennett, et. al.Charles L Bennett ... Stephen Y Lai
16 Nov 2008
Assessing adherence to the European Organization for Research and Treatment of Cancer (EORTC) guidelines for the use of erythropoiesis-stimulating agents in cancer patients
J Castro ... J M Muñoz-Langa
Journal of Clinical Oncology | VOL. 26
J Castro, et. al.J Castro ... J M Muñoz-Langa
20 May 2008
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
276MO Epidemiology, treatment (tx) patterns, and clinical outcomes of patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) in Taiwan: A retrospective cohort study
C-T Wu ... L-N Chien
Annals of Oncology | VOL. 35
C-T Wu, et. al.C-T Wu ... L-N Chien
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.